VPC News

Many men survive prostate cancer, but thousands of others — whose cancer spreads — inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life. Now, armed with a new $10 million grant, a multi-centre “dream team’’ of...

The breakthrough collaborative work being done by Drs. Colin Collins and Yuzhuo Wang of the Vancouver Prostate Centre is featured in a three-page article in the latest issue of "International Innovation" magazine. Click here to view the whole article as a PDF.

VANCOUVER, BRITISH COLUMBIA – The Vancouver Prostate Centre announced today an extended collaboration with AstraZeneca that sees the Vancouver Prostate Centre receive $700,000 over two years towards research that targets treatment-resistant prostate cancer. The research, which is being coordinated...

Toronto, ON – January 28, 2013 – Prostate Cancer Canada (PCC) is proud to announce the recipients of the Rising Star in Prostate Cancer Research program. In its inaugural year, the Movember-funded Rising Star program provides funding to four outstanding scientists to support careers as independent...

A three-minute clip on the Vancouver Prostate Centre and one of our novel approaches to designing therapeutic drugs was featured on Global TV evening news on Monday September 17, 2012. The video includes interviews with patient Don Konantz and research scientists Dr. Colin Collins and Dr. Artem...

NEWS RELEASE Monday September 17, 2012 Vancouver, BC – Researchers at the Vancouver Prostate Centre at Vancouver Coastal Health and UBC are undertaking a revolutionary approach to find new drug therapies and molecular targets that will help prostate cancer patients who have become resistant to...

A new study co-authored by Dr. Larry Goldenberg, urologic surgeon and researcher at the Vancouver Prostate Centre and head of the Department Urologic Sciences at UBC, has shown that prostate cancer patients who are given a “drug holiday” have the same survival rate as the continuous treatment group...

Drs. Martin Gleave and Colin Collins part of new pan-Canadian prostate cancer network A new pan-Canadian network of prostate cancer researchers formed by the Terry Fox Research Institute (TFRI) aims to address this need with approximately $4-million provided by the Terry Fox Foundation and the...